Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Study of HRS-8797 in Healthy Participants
Sponsor: Chengdu Suncadia Medicine Co., Ltd.
Summary
The purpose of this phase I study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-8797 in healthy participants.
Official title: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect Following Single and Multiple Oral Doses of HRS-8797 Tablets in Healthy Subjects
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
74
Start Date
2026-07
Completion Date
2027-01
Last Updated
2026-07-13
Healthy Volunteers
Yes
Conditions
Interventions
HRS-8797
Specified dose on specified days
Placebo
Specified dose on specified days
Locations (1)
The First Hospital of Jilin University
Changchun, Jilin, China